Proteomic analysis of microvesicles derived from human colorectal cancer cells

Journal of Proteome Research

Volumn 6, Issue 12, 2007, Pages 4646-4655

  Choi, Dong Sic ^a   Lee, Jae Min ^a   Gun, Wook Park ^b   Lim, Hyeon Woo ^a   Joo, Young Bang ^d   Kim, Yoon Keun ^a   Kwon, Kyung Hoon ^b   Ho, Jeong Kwon ^c   Kwang, Pyo Kim ^d   Yong, Song Gho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Yonsei University   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Colorectal cancer; Communicasomes; Exosomes; HT29; Microparticles; Microvesicles; Proteomics; Tolerosomes

Indexed keywords

ANNEXIN; RAB PROTEIN;

ANGIOGENESIS; ARTICLE; BIOGENESIS; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL COMMUNICATION; CELL MIGRATION; CELL TYPE; COLORECTAL CANCER; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE VESICLE; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEOMICS;

ANIMALS; CELL FRACTIONATION; COLORECTAL NEOPLASMS; CYTOPLASMIC VESICLES; HT29 CELLS; HUMANS; MICE; NEOPLASM PROTEINS; PROTEOMICS;

EID: 38048999426     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070192y     Document Type: Article

References (68)

1. Ratajczak, J.; Wysoczynski, M.; Hayek, F.; Janowska-Wieczorek, A.; Ratajczak, M. Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20, 1487-1495.
2. Mashburn-Warren, L. M.; Whiteley, M. Special delivery: vesicle trafficking in prokaryotes. Mol. Microbiol. 2006, 61, 839-846.
3. Thery, C.; Zitvogel, L.; Amigorena, S. Exosomes: composition, biogenesis and function. Nat Rev. Immunol. 2002, 2, 569-579.
4. Fevrier, B.; Raposo, G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16, 415-421.
5. Van Niel, G.; Raposo, G.; Candalh, C.; Boussac, M.; Hershberg, R.; Cerf-Bensussan, N.; Heyman, M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001, 121, 337-349.
6. Van Niel, G.; Mallegol, J.; Bevilacqua, C.; Candalh, C.; Brugiere, S.; Tomaskovic-Crook, E.; Heath, J. K.; Cerf-Bensussan, N.; Heyman, M. Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Gut 2003, 52, 1690-1697.
7. Banfi, C.; Brioschi, M.; Wait, R.; Begum, S.; Gianazza, E.; Pirillo, A.; Mussoni, L.; Tremoli, E. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005, 5, 4443-4455.
8. Mears, R.; Craven, R. A.; Hanrahan, S.; Totty, N.; Upton, C.; Young, S. L.; Patel, P.; Selby, P. J.; Banks, R. E. Proteomic analysis of melanoma-derived exosomes by two-dimensional Polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 4019-4031.
9. Miguet, L.; Pacaud, K.; Felden, C.; Hugel, B.; Martinez, M. C.; Freyssinet, J. M.; Herbrecht, R.; Potier, N.; van Dorsselaer, A.; Mauvieux, L. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2006, 6, 153-171.
10. Garcia, B. A.; Smalley, D. M.; Cho, H.; Shabanowitz, J.; Ley, K.; Hunt, D. F. The platelet microparticle proteome. J. Proteome Res. 2005, 4, 1516-1521.
11. Pisitkun, T.; Shen, R. F.; Knepper, M. A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 13368-13373.
12. Utleg, A. G.; Yi, E. C.; Xie, T.; Shannon, P.; White, J. T.; Goodlett, D. R.; Hood, L.; Lin, B. Proteomic analysis of human prostasomes. Prostate 2003, 56, 150-161.
13. Hegmans, J. P.; Bard, M. P.; Hemmes, A.; Luider, T. M.; Kleijmeer, M. J.; Prins, J. B.; Zitvogel, L.; Burgers, S. A.; Hoogsteden, H. C.; Lambrecht, B. N. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 2004, 164, 1807-1815.
14. Wubbolts, R.; Leckie, R. S.; Veenhuizen, P. T.; Schwarzmann, G.; Mobius, W.; Hoernschemeyer, J.; Slot, J. W.; Geuze, H. J.; Stoorvogel, W. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 2003, 278, 10963-10972.
15. Jin, M.; Drwal, G.; Bourgeois, T.; Saltz, J.; Wu, H. M. Distinct proteome features of plasma microparticles. Proteomics 2005, 5, 1940-1952.
16. Bard, M. P.; Hegmans, J. P.; Hemmes, A.; Luider, T. M.; Willemsen, R.; Severijnen, L. A.; van Meerbeeck, J. P.; Burgers, S. A.; Hoogsteden, H. C.; Lambrecht, B. N. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 2004, 31, 114-121.
17. Shedden, K.; Xie, X. T.; Chandaroy, P.; Chang, Y. T.; Rosania, G. R. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003, 63, 4331-4337.
18. Chen, V. Y.; Posada, M. M.; Blazer, L. L.; Zhao, T.; Rosania, G. R. The role of the VPS4A-exosome pathway in the intrinsic egress route of a DNA-binding anticancer drug. Pharm. Res. 2006, 23, 1687-1695.
19. Ginestra, A.; Miceli, D.; Dolo, V.; Romano, F. M.; Vittorelli, M. L. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res. 1999, 19, 3439-3445.
20. Ginestra, A.; La Placa, M. D.; Saladino, F.; Cassara, D.; Nagase, H.; Vittorelli, M. L. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 1998, 18, 3433-3437.
21. Escudier, B.; Dorval, T.; Chaput, N.; Andre, F.; Caby, M. P.; Novault, S.; Flament, C.; Leboulaire, C.; Borg, C.; Amigorena, S.; Boccaccio, C.; Bonnerot, C.; Dhellin, O.; Movassagh, M.; Piperno, S.; Robert, C.; Serra, V.; Valente, N.; Le Pecq, J. B.; Spatz, A.; Lantz, O.; Tursz, T.; Angevin, E.; Zitvogel, L. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med. 2005, 3, 10.
22. Kerr, D. Clinical development of gene therapy for colorectal cancer. Nat. Rev. Cancer 2003, 3, 615-622.
23. Huber, V.; Fais, S.; Iero, M.; Lugini, L.; Canese, P.; Squarcina, P.; Zaccheddu, A.; Colone, M.; Arancia, G.; Gentile, M.; Seregni, E.; Valenti, R.; Ballabio, G.; Belli, F.; Leo, E.; Parmiani, G.; Rivoltini, L. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005, 128, 1796-1804.
24. Karlsson, M.; Lundin, S.; Dahlgren, U.; Kahu, H.; Pettersson, I.; Telemo, E. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 2001, 31, 2892-2900.
25. Moore, R. E.; Young, M. K.; Lee, T. D. Qscore: an algorithm for evaluating SEQUEST database search results. J. Am. Soc. Mass Spectrom. 2002, 13, 378-386.
26. Park, G. W.; Kwon, K. H.; Kim, J. Y.; Lee, J. H.; Yun, S. H.; Kim, S. I.; Park, Y. M.; Cho, S. Y.; Paik, Y. K.; Yoo, J. S. Human plasma proteome analysis by reversed sequence database search and molecular weight correlation based on a bacterial proteome analysis. Proteomics 2006, 6, 1121-1132.
27. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
28. Lamparski, H. G.; Metha-Damani, A.; Yao, J. Y.; Patel, S.; Hsu, D. H.; Ruegg, C.; Le Pecq, J. B. Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 2002, 270, 211-226.
29. Fevrier, B.; Vilette, D.; Archer, F.; Loew, D.; Faigle, W.; Vidal, M.; Laude, H.; Raposo, G. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 9683-9688.
30. Thery, C.; Boussac, M.; Veron, P.; Ricciardi-Castagnoli, P.; Raposo, G.; Garin, J.; Amigorena, S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001, 166, 7309-7318.
31. Sadygov, R. G.; Eng, J.; Durr, E.; Saraf, A.; McDonald, H.; MacCoss, M. J.; Yates, J. R. 3rd, Code developments to improve the efficiency of automated MS/MS spectra interpretation. J Proteome Res. 2002, 1, 211-215.
32. Chang, G. C.; Liu, K. J.; Hsieh, C. L.; Hu, T. S.; Charoenfuprasert, S.; Liu, H. K.; Luh, K. T.; Hsu, L. H.; Wu, C. W.; Ting, C. C.; Chen, C. Y.; Chen, K. C.; Yang, T. Y.; Chou, T. Y.; Wang, W. H.; Whang-Peng, J.; Shih, N. Y. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin. Cancer Res. 2006, 12, 5746-5754.
33. Hardt, P. D.; Mazurek, S.; Toepler, M.; Schlierbach, P.; Bretzel, R. G.; Eigenbrodt, E.; Kloer, H. U. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br. J. Cancer 2004, 91, 980-984.
34. Neckers, L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol. Med. 2002, 8, S55-61.
35. Bodnar, W. M.; Blackburn, R. K.; Krise, J. M.; Moseley, M. A. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J. Am. Soc. Mass Spectrom. 2003, 14, 971-979.
36. Zerial, M.; McBride, H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001, 2, 107-117.
37. Seabra, M. C.; Mules, E. H.; Hume, A. N. Rab GTPases, intracellular traffic and disease. Trends Mol. Med. 2002, 8, 23-30.
38. Kouranti, I.; Sachse, M.; Arouche, N.; Goud, B.; Echard, A. Rab35 regulates an endocytic recycling pathway essential for the terminal steps of cytokinesis. Curr. Biol. 2006, 16, 1719-1725.
39. Stein, M. P.; Dong, J.; Wandinger-Ness, A. Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. Adv. Drug Delivery Rev. 2003, 55, 1421-1437.
40. Cheng, K. W.; Lahad, J. P.; Gray, J. W.; Mills, G. B. Emerging role of RAB GTPases in cancer and human disease. Cancer Res. 2005, 65, 2516-2519.
41. Folkman, J. What is the evidence that tumors are angiogenesis dependent. J. Natl. Cancer Inst. 1990, 82, 4-6.
42. Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chem. 1992, 267, 10931-10934.
43. Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases. Nature 2000, 407, 249-257.
44. Kim, C. W.; Lee, H. M.; Lee, T. H.; Kang, C.; Heinman, H. K.; Gho, Y. S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002, 62, 6312-6317.
45. Millimaggi, D.; Mari, M.; D'Ascenzo, S.; Carosa, E.; Jannini, E. A.; Zucker, S.; Carta, G.; Pavan, A.; Dolo, V. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 2007, 9, 349-357.
46. Brill, A.; Elinav, H.; Varon, D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc. Res. 2004, 63, 226-235.
47. Gesierich, S.; Berezovskiy, I.; Ryschich, E.; Zoller, M. Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/ CO-029. Cancer Res. 2006, 66, 7083-7094.
48. Gutwein, P.; Mechtersheimer, S.; Riedle, S.; Stoeck, A.; Gast, D.; Ioumaa, S.; Zentgraf, H.; Fogel, M.; Altevogt, D. P. ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J. 2003, 17, 292-294.
49. Gutwein, P.; Stoeck, A.; Riedle, S.; Gast, D.; Runz, S.; Condon, T. P.; Marme, A.; Phong, M. C.; Linderkamp, O.; Skorokhod, A.; Altevogt, P. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 2005, 11, 2492-2501.
50. Hall, H.; Djonov, V.; Ehrbar, M.; Hoechli, M.; Hubbell, J. A. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis 2004, 7, 213-223.
51. Trochon, V.; Li, H.; Vasse, M.; Frankenne, F.; Thomaidis, A.; Soria, J.; Lu, H.; Gardner, C.; Soria, C. Endothelial metalloprotease-disintegrin protein (ADAM) is implicated in angiogenesis in vitro. Angiogenesis 1998, 2, 277-285.
52. Lakshman, M.; Subramaniam, V.; Rubenthiran, U.; Jothy, S. CD44 promotes resistance to apoptosis in human colon cancer cells. Exp. Mol. Pathol. 2004, 77, 18-25.
53. Murray, D.; Morrin, M.; McDonnell, S. Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism. Anticancer Res. 2004, 24, 489-494.
54. Gotte, M.; Yip, G. W. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 2006, 66, 10233-10237.
55. Griffioen, A. W.; Coenen, M. J.; Damen, C. A.; Hellwig, S. M.; van Weering, D. H.; Vooys, W.; Blijham, G. H.; Groenewegen, G. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood 1997, 90, 1150-1159.
56. Schlingemann, R. O.; Rietveld, F. J.; de Waal, R. M.; Ferrone, S.; Ruiter, D. J. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am. J. Pathol. 1990, 136, 1393-1405.
57. Fukushi, J.; Makagiansar, I. T.; Stallcup, W. B. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3betal integrin. Mol. Biol. Cell 2004, 15, 3580-3590.
58. Goretzki, L.; Burg, M. A.; Grako, K. A.; Stallcup, W. B. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J. Biol. Chem. 1999, 274, 16831-16837.
59. Sawai, Y.; Tamura, S.; Fukui, K.; Ito, N.; Imanaka, K.; Saeki, A.; Sakuda, S.; Kiso, S.; Matsuzawa, Y. Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization. J. Hepatol. 2003, 39, 991-996.
60. Tanaka, M.; Sasaki, K.; Kamata, R.; Sakai, R. The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells. J. Cell Sci. 2007, 120, 2179-2189.
61. Varelias, A.; Koblar, S. A.; Cowled, P. A.; Carter, C. D.; Clayer, M. Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenjcity and prognosis. Cancer 2002, 95, 862-869.
62. Mitchell, R. A.; Bucala, R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin. Cancer Biol. 2000, 10, 359-366.
63. Hira, E.; Ono, T.; Dhar, D. K.; El-Assal, O. N.; Hishikawa, Y.; Yamanoi, A.; Nagasue, N. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer 2005, 103, 588-598.
64. Nishihira, J.; Ishibashi, T.; Fukushima, T.; Sun, B.; Sato, Y.; Todo, S. Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann. N.Y. Acad. Sci. 2003, 995, 171-182.
65. Shun, C. T.; Lin, J. T.; Huang, S. P.; Lin, M. T.; Wu, M. S. Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J. Gastroenterol. 2005, 11, 3767-3771.
66. Berns, H.; Humar, R.; Hengerer, B.; Kiefer, F. N.; Battegay, E. J. RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J. 2000, 14, 2549-2558.
67. Gesierich, S.; Paret, C.; Hildebrand, D.; Weitz, J.; Zgraggen, K.; Schmitz-Winnenthal, F. H.; Horejsi, V.; Yoshie, O.; Herlyn, D.; Ashman, L. K.; Zoller, M. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin. Cancer Res. 2005, 11, 2840-2852.
68. Soreide, K.; Janssen, E. A.; Soiland, H.; Korner, H.; Baak, J. P. Microsatellite instability in colorectal cancer. Br. J. Surg. 2006, 93, 395-406.